A novel approach to deep venous arterialization using WavelinQ EndoAVF technology.

Autor:	Pickering OK; Department of Vascular and Endovascular Surgery, Flinders Medical Centre, Adelaide, SA, Australia., Ramachandren TK; Department of Vascular and Endovascular Surgery, Flinders Medical Centre, Adelaide, SA, Australia.; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia., Mortensen R; Department of Vascular and Endovascular Surgery, Flinders Medical Centre, Adelaide, SA, Australia., Delaney CL; Department of Vascular and Endovascular Surgery, Flinders Medical Centre, Adelaide, SA, Australia.; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Jazyk:	angličtina
Zdroj:	Journal of vascular surgery cases and innovative techniques [J Vasc Surg Cases Innov Tech] 2023 Dec 29; Vol. 10 (3), pp. 101407. Date of Electronic Publication: 2023 Dec 29 (Print Publication: 2024).
DOI:	10.1016/j.jvscit.2023.101407
Abstrakt:	Deep venous arterialization is increasingly being considered for the management of patients with "no option chronic limb threatening ischemia" (CLTI) who would otherwise require a major limb amputation. WavelinQ (Becton Dickinson) is a new technology increasing in popularity for its role in the formation of endovascular arteriovenous fistulas but might well have applications in other areas of vascular surgery. We present a novel approach to deep venous arterialization using WavelinQ arteriovenous fistula technology for a patient with nonreconstructable chronic limb threatening ischemia experiencing both rest pain and forefoot gangrene. The patient's early tissue loss healed and he remained symptom free at 6 months after the intervention. Competing Interests: C.L.D. has a consulting role with Becton Dickinson. O.K.P., T.K.R., and R.M. have no conflicts of interest. (© 2023 Published by Elsevier Inc. on behalf of Society for Vascular Surgery.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu